Invitation to Elekta’s full-year report conference call

Elekta will publish its full-year report for 2011/12 on June 5, 2012 with the
following schedule:

  · The report will be published at 07:30 CET.
  · Elekta will host a telephone conference at 10:00-11:00 CET, with Tomas
Puusepp, President and CEO and Håkan Bergström, CFO.

To take part in the conference call, please dial in about 5-10 minutes in
advance and use the access code 917247.

  · Swedish dial-in number: +46 (0)8 5052 0110
  · UK dial-in number: +44 (0)20 7162 0077
  · US dial-in number: + 1 334 323 6201

The telephone conference will also be broadcast live online (audio only). Please
use this link: http://webeventservices.reg.meeting-stream.com/64156_elekta
Elekta’s Capital Markets Day – June 19, 2012 in Stockholm
Elekta invites equity analysts, investors and media representatives to a Capital
Markets Day in Stockholm, June 19. Tomas Puusepp, President and CEO, and other
members of Elekta’s management team will give presentations focusing on Elekta’s
strategy and development. Lunch will be served from 12:15 CET and the
presentations will start at 13:00 and end at approximately 15:30. The venue is
Grand Hotel, Stockholm, Sweden.

To attend this Capital Markets Day, please register by e-mail to
johan.anderssonmelbi@elekta.com no later than June 5, 2012.

For further information, please contact: Johan Andersson Melbi, Investor
Relations Manager, Elekta AB +46 702 100 451, johan.anderssonmelbi@elekta.com.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare providers
and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,300 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb.